Responses
Regular and young investigator award abstracts
Immuno-conjugates and chimeric molecules
635 A novel site-directed chemical conjugation technology confers antitumor activity via native Fc receptor to plasma immunoglobulin by attaching tumor binders
Compose a Response to This Article
Other responses
No responses have been published for this article.
